IBDEI0IN ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18783,0)
 ;;=D45.^^84^967^71
 ;;^UTILITY(U,$J,358.3,18783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18783,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,18783,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,18783,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,18784,0)
 ;;=D47.Z9^^84^967^72
 ;;^UTILITY(U,$J,358.3,18784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18784,1,3,0)
 ;;=3^Neop of Uncertain Behavior of Lymphoid/Hematpoetc/Related Tissue
 ;;^UTILITY(U,$J,358.3,18784,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,18784,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,18785,0)
 ;;=C94.40^^84^967^73
 ;;^UTILITY(U,$J,358.3,18785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18785,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
 ;;^UTILITY(U,$J,358.3,18785,1,4,0)
 ;;=4^C94.40
 ;;^UTILITY(U,$J,358.3,18785,2)
 ;;=^5001843
 ;;^UTILITY(U,$J,358.3,18786,0)
 ;;=C94.41^^84^967^74
 ;;^UTILITY(U,$J,358.3,18786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18786,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,18786,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,18786,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,18787,0)
 ;;=C94.42^^84^967^75
 ;;^UTILITY(U,$J,358.3,18787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18787,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,18787,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,18787,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,18788,0)
 ;;=D47.1^^84^967^76
 ;;^UTILITY(U,$J,358.3,18788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18788,1,3,0)
 ;;=3^Chronic Myeloproliferative Disease
 ;;^UTILITY(U,$J,358.3,18788,1,4,0)
 ;;=4^D47.1
 ;;^UTILITY(U,$J,358.3,18788,2)
 ;;=^5002256
 ;;^UTILITY(U,$J,358.3,18789,0)
 ;;=D47.9^^84^967^77
 ;;^UTILITY(U,$J,358.3,18789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18789,1,3,0)
 ;;=3^Neop of Uncertain Behavior of Lymphoid/Hematpoetc/Related Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,18789,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,18789,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,18790,0)
 ;;=D47.Z9^^84^967^78
 ;;^UTILITY(U,$J,358.3,18790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18790,1,3,0)
 ;;=3^Neop of Uncertain Behavior of Lymphoid/Hematpoetc/Related Tissue,NEC
 ;;^UTILITY(U,$J,358.3,18790,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,18790,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,18791,0)
 ;;=A15.0^^84^968^103
 ;;^UTILITY(U,$J,358.3,18791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18791,1,3,0)
 ;;=3^Tuberculosis of Lung
 ;;^UTILITY(U,$J,358.3,18791,1,4,0)
 ;;=4^A15.0
 ;;^UTILITY(U,$J,358.3,18791,2)
 ;;=^5000062
 ;;^UTILITY(U,$J,358.3,18792,0)
 ;;=A31.0^^84^968^87
 ;;^UTILITY(U,$J,358.3,18792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18792,1,3,0)
 ;;=3^Pulmonary Mycobacterial Infection
 ;;^UTILITY(U,$J,358.3,18792,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,18792,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,18793,0)
 ;;=B95.5^^84^968^93
 ;;^UTILITY(U,$J,358.3,18793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18793,1,3,0)
 ;;=3^Streptococcus in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18793,1,4,0)
 ;;=4^B95.5
 ;;^UTILITY(U,$J,358.3,18793,2)
 ;;=^5000840
 ;;^UTILITY(U,$J,358.3,18794,0)
 ;;=B95.0^^84^968^95
 ;;^UTILITY(U,$J,358.3,18794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18794,1,3,0)
 ;;=3^Streptococcus,Group A,in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18794,1,4,0)
 ;;=4^B95.0
 ;;^UTILITY(U,$J,358.3,18794,2)
 ;;=^5000835
 ;;^UTILITY(U,$J,358.3,18795,0)
 ;;=B95.1^^84^968^96
 ;;^UTILITY(U,$J,358.3,18795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18795,1,3,0)
 ;;=3^Streptococcus,Group B,in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18795,1,4,0)
 ;;=4^B95.1
 ;;^UTILITY(U,$J,358.3,18795,2)
 ;;=^5000836
 ;;^UTILITY(U,$J,358.3,18796,0)
 ;;=B95.4^^84^968^94
 ;;^UTILITY(U,$J,358.3,18796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18796,1,3,0)
 ;;=3^Streptococcus in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,18796,1,4,0)
 ;;=4^B95.4
 ;;^UTILITY(U,$J,358.3,18796,2)
 ;;=^5000839
 ;;^UTILITY(U,$J,358.3,18797,0)
 ;;=B95.2^^84^968^48
 ;;^UTILITY(U,$J,358.3,18797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18797,1,3,0)
 ;;=3^Enterococcus in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18797,1,4,0)
 ;;=4^B95.2
 ;;^UTILITY(U,$J,358.3,18797,2)
 ;;=^5000837
 ;;^UTILITY(U,$J,358.3,18798,0)
 ;;=B95.8^^84^968^92
 ;;^UTILITY(U,$J,358.3,18798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18798,1,3,0)
 ;;=3^Staphylococcus,Unspec,in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18798,1,4,0)
 ;;=4^B95.8
 ;;^UTILITY(U,$J,358.3,18798,2)
 ;;=^5000844
 ;;^UTILITY(U,$J,358.3,18799,0)
 ;;=B95.61^^84^968^77
 ;;^UTILITY(U,$J,358.3,18799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18799,1,3,0)
 ;;=3^Methicillin Suscept Staph Infct in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18799,1,4,0)
 ;;=4^B95.61
 ;;^UTILITY(U,$J,358.3,18799,2)
 ;;=^5000841
 ;;^UTILITY(U,$J,358.3,18800,0)
 ;;=B95.62^^84^968^76
 ;;^UTILITY(U,$J,358.3,18800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18800,1,3,0)
 ;;=3^Methicillin Resist Staph Infct in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18800,1,4,0)
 ;;=4^B95.62
 ;;^UTILITY(U,$J,358.3,18800,2)
 ;;=^5000842
 ;;^UTILITY(U,$J,358.3,18801,0)
 ;;=B95.7^^84^968^91
 ;;^UTILITY(U,$J,358.3,18801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18801,1,3,0)
 ;;=3^Staphylococcus in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18801,1,4,0)
 ;;=4^B95.7
 ;;^UTILITY(U,$J,358.3,18801,2)
 ;;=^5000843
 ;;^UTILITY(U,$J,358.3,18802,0)
 ;;=B96.1^^84^968^70
 ;;^UTILITY(U,$J,358.3,18802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18802,1,3,0)
 ;;=3^Klebsiella Pneumoniae in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,18802,1,4,0)
 ;;=4^B96.1
 ;;^UTILITY(U,$J,358.3,18802,2)
 ;;=^5000846
 ;;^UTILITY(U,$J,358.3,18803,0)
 ;;=B96.20^^84^968^49
 ;;^UTILITY(U,$J,358.3,18803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18803,1,3,0)
 ;;=3^Escherichia Coli in Diseases Classified Elsewhere,Unspec
 ;;^UTILITY(U,$J,358.3,18803,1,4,0)
 ;;=4^B96.20
 ;;^UTILITY(U,$J,358.3,18803,2)
 ;;=^5000847
 ;;^UTILITY(U,$J,358.3,18804,0)
 ;;=B96.29^^84^968^50
 ;;^UTILITY(U,$J,358.3,18804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18804,1,3,0)
 ;;=3^Escherichia Coli in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,18804,1,4,0)
 ;;=4^B96.29
 ;;^UTILITY(U,$J,358.3,18804,2)
 ;;=^5000851
 ;;^UTILITY(U,$J,358.3,18805,0)
 ;;=B20.^^84^968^58
 ;;^UTILITY(U,$J,358.3,18805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18805,1,3,0)
 ;;=3^HIV Disease
 ;;^UTILITY(U,$J,358.3,18805,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,18805,2)
 ;;=^5000555
 ;;^UTILITY(U,$J,358.3,18806,0)
 ;;=B02.9^^84^968^108
 ;;^UTILITY(U,$J,358.3,18806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18806,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,18806,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,18806,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,18807,0)
 ;;=A60.9^^84^968^14
 ;;^UTILITY(U,$J,358.3,18807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18807,1,3,0)
 ;;=3^Anogenital Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,18807,1,4,0)
 ;;=4^A60.9
 ;;^UTILITY(U,$J,358.3,18807,2)
 ;;=^5000359
 ;;^UTILITY(U,$J,358.3,18808,0)
 ;;=A60.04^^84^968^65
 ;;^UTILITY(U,$J,358.3,18808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18808,1,3,0)
 ;;=3^Herpesviral Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,18808,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,18808,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,18809,0)
 ;;=A60.01^^84^968^63
 ;;^UTILITY(U,$J,358.3,18809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18809,1,3,0)
 ;;=3^Herpesviral Infection of Penis
 ;;^UTILITY(U,$J,358.3,18809,1,4,0)
 ;;=4^A60.01
 ;;^UTILITY(U,$J,358.3,18809,2)
 ;;=^5000353
